Market News

The Ups and Downs of Biolase Stock: A Financial Review of Q4 2023 Earnings

by Ron Finklestien

Updated On: March 22, 2024 1:58 am

BIOL stock - Biolase Stock Earnings for Q4 2023

Source: iQoncept / Shutterstock

Biolase (NASDAQ:BIOL) recently unveiled its performance for the final quarter of 2023.

The earnings per share stood at -$1.76, surpassing the expected EPS of -$2.55.
However, the company recorded revenue of $13.49 million, falling slightly short of the anticipated $13.55 million.

InvestorPlace Earnings, powered by TradeSmith data, succinctly presents crucial details from quarterly earnings reports. The analysis covers earnings per share, revenue figures, and the company’s alignment with analyst projections. These reports are produced promptly and without direct human input, ensuring swift dissemination of financial insights. Any discrepancies or issues can be reported to [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/biol-stock-earnings-biolase-for-q4-of-2023/.